258 related articles for article (PubMed ID: 16253598)
1. Relation of the prothrombotic state to increasing age (from the Framingham Offspring Study).
Tofler GH; Massaro J; Levy D; Mittleman M; Sutherland P; Lipinska I; Muller JE; D'Agostino RB
Am J Cardiol; 2005 Nov; 96(9):1280-3. PubMed ID: 16253598
[TBL] [Abstract][Full Text] [Related]
2. Nonvalvular atrial fibrillation: evidence for a prothrombotic state.
Kahn SR; Solymoss S; Flegel KM
CMAJ; 1997 Sep; 157(6):673-81. PubMed ID: 9307553
[TBL] [Abstract][Full Text] [Related]
3. Plasma fibrinogen, haemostatic factors and prediction of peripheral arterial disease in the Edinburgh Artery Study.
Smith FB; Lee AJ; Hau CM; Rumley A; Lowe GD; Fowkes FG
Blood Coagul Fibrinolysis; 2000 Jan; 11(1):43-50. PubMed ID: 10691098
[TBL] [Abstract][Full Text] [Related]
4. Altered endothelial function following the Fontan procedure.
Binotto MA; Maeda NY; Lopes AA
Cardiol Young; 2008 Feb; 18(1):70-4. PubMed ID: 18093358
[TBL] [Abstract][Full Text] [Related]
5. C-reactive protein, prothrombotic imbalance and endothelial dysfunction in acute coronary syndromes without ST elevation.
Apetrei E; Ciobanu-Jurcuţ R; Rugină M; Gavrilă A; Uscătescu V
Rom J Intern Med; 2004; 42(1):95-102. PubMed ID: 15529598
[TBL] [Abstract][Full Text] [Related]
6. Increased heart rate is associated with a prothrombotic state: The Framingham Heart Study.
Tofler GH; Massaro J; Levy DA; Sutherland PA; Buckley T; D'Agostino RB
Eur J Prev Cardiol; 2017 Mar; 24(4):382-388. PubMed ID: 27856811
[TBL] [Abstract][Full Text] [Related]
7. Haemostatic factors and the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study.
Morange PE; Bickel C; Nicaud V; Schnabel R; Rupprecht HJ; Peetz D; Lackner KJ; Cambien F; Blankenberg S; Tiret L;
Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2793-9. PubMed ID: 17023678
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of Framingham offspring participants with long-lived parents.
Terry DF; Evans JC; Pencina MJ; Murabito JM; Vasan RS; Wolf PA; Kelly-Hayes M; Levy D; D'Agostino RB; Benjamin EJ
Arch Intern Med; 2007 Mar; 167(5):438-44. PubMed ID: 17353490
[TBL] [Abstract][Full Text] [Related]
9. Relation of depressive mood to plasminogen activator inhibitor, tissue plasminogen activator, and fibrinogen levels in patients with versus without coronary heart disease.
Lahlou-Laforet K; Alhenc-Gelas M; Pornin M; Bydlowski S; Seigneur E; Benetos A; Kierzin JM; Scarabin PY; Ducimetiere P; Aiach M; Guize L; Consoli SM
Am J Cardiol; 2006 May; 97(9):1287-91. PubMed ID: 16635597
[TBL] [Abstract][Full Text] [Related]
10. Association of European population levels of thrombotic and inflammatory factors with risk of coronary heart disease: the MONICA Optional Haemostasis Study.
Yarnell J; McCrum E; Rumley A; Patterson C; Salomaa V; Lowe G; Evans A
Eur Heart J; 2005 Feb; 26(4):332-42; discussion 317-8. PubMed ID: 15618045
[TBL] [Abstract][Full Text] [Related]
11. Hemostatic factors and cardiovascular disease in active rheumatoid arthritis: an 8 year followup study.
Wållberg-Jonsson S; Cederfelt M; Rantapää Dahlqvist S
J Rheumatol; 2000 Jan; 27(1):71-5. PubMed ID: 10648020
[TBL] [Abstract][Full Text] [Related]
12. Multimarker approach to evaluate the incidence of the metabolic syndrome and longitudinal changes in metabolic risk factors: the Framingham Offspring Study.
Ingelsson E; Pencina MJ; Tofler GH; Benjamin EJ; Lanier KJ; Jacques PF; Fox CS; Meigs JB; Levy D; Larson MG; Selhub J; D'Agostino RB; Wang TJ; Vasan RS
Circulation; 2007 Aug; 116(9):984-92. PubMed ID: 17698726
[TBL] [Abstract][Full Text] [Related]
13. Haemorheological, platelet and endothelial indices in relation to global measures of cardiovascular risk in hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
Spencer CG; Felmeden DC; Blann AD; Lip GY
J Intern Med; 2007 Jan; 261(1):82-90. PubMed ID: 17222171
[TBL] [Abstract][Full Text] [Related]
14. Association between increased homocysteine levels and impaired fibrinolytic potential: potential mechanism for cardiovascular risk.
Tofler GH; D'Agostino RB; Jacques PF; Bostom AG; Wilson PW; Lipinska I; Mittleman MA; Selhub J
Thromb Haemost; 2002 Nov; 88(5):799-804. PubMed ID: 12428097
[TBL] [Abstract][Full Text] [Related]
15. Hemostatic factors, inflammatory markers, and progressive peripheral atherosclerosis: the Edinburgh Artery Study.
Tzoulaki I; Murray GD; Price JF; Smith FB; Lee AJ; Rumley A; Lowe GD; Fowkes FG
Am J Epidemiol; 2006 Feb; 163(4):334-41. PubMed ID: 16357107
[TBL] [Abstract][Full Text] [Related]
16. Endothelial haemostatic factors are associated with progression of urinary albumin excretion in clinically healthy subjects: a 4-year prospective study.
Clausen P; Feldt-Rasmussen B; Jensen G; Jensen JS
Clin Sci (Lond); 1999 Jul; 97(1):37-43. PubMed ID: 10369792
[TBL] [Abstract][Full Text] [Related]
17. Tissue plasminogen activator, von Willebrand factor, and risk of type 2 diabetes in older men.
Wannamethee SG; Sattar N; Rumley A; Whincup PH; Lennon L; Lowe GD
Diabetes Care; 2008 May; 31(5):995-1000. PubMed ID: 18235054
[TBL] [Abstract][Full Text] [Related]
18. Hemostatic factors and risk of cardiovascular disease in women. An overview.
Meilahn EN
Arch Pathol Lab Med; 1992 Dec; 116(12):1313-7. PubMed ID: 1456877
[TBL] [Abstract][Full Text] [Related]
19. Plasma levels of free and total TFPI, relationship with cardiovascular risk factors and endothelial cell markers.
Morange PE; Renucci JF; Charles MA; Aillaud MF; Giraud F; Grimaux M; Juhan-Vague I
Thromb Haemost; 2001 Jun; 85(6):999-1003. PubMed ID: 11434709
[TBL] [Abstract][Full Text] [Related]
20. Increased cardiovascular risk markers in obesity are associated with body adiposity: role of leptin.
Gómez-Ambrosi J; Salvador J; Silva C; Pastor C; Rotellar F; Gil MJ; Cienfuegos JA; Frühbeck G
Thromb Haemost; 2006 Jun; 95(6):991-6. PubMed ID: 16732378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
